EGFR and colorectal cancer: In order to overcome the versatility and extreme adaptability of colorectal cancer, we produced and characterized several designs of ITXs, based on the VHH 7D12 [45] that binds to the EGFR extracellular domain III, preventing its dimerization and subsequent signaling activity and thus taking advantage of the unique features of nanobodies as the target domain.